adtn-ex991

	Three Months ended June 30,								Six Months ended June 30,
	2019				2018				2019				2018
Operating Income (Loss)	$	562			$	(12,813	)		$	(5,605	)		$	(39,460	)
Acquisition related expenses, amortizations and adjustments		1,506		⁽¹⁾		1,142		⁽⁷⁾		3,003		⁽¹⁰⁾		1,725		⁽¹³⁾
Stock-based compensation expense		1,454		⁽²⁾		1,784		⁽⁸⁾		3,313		⁽¹¹⁾		3,603		⁽¹⁴⁾
Restructuring expenses		1,400		⁽³⁾		1,025		⁽⁹⁾		3,463		⁽¹²⁾		6,975		⁽¹⁵⁾
Deferred compensation income (expense)		683		⁽⁴⁾		132		⁽⁴⁾		2,807		⁽⁴⁾		(254	)	⁽⁴⁾
Gain on contingency		(1,230	)	⁽⁵⁾		—				(1,230	)	⁽⁵⁾		—
Settlement income		(746	)	⁽⁶⁾		—				(746	)	⁽⁶⁾		—
Non-GAAP Operating Income (Loss)	$	3,629			$	(8,730	)		$	5,005			$	(27,411	)

⁽¹⁾ $0.4 million is included in total cost of sales, $0.6 million is included in selling, general and administrative expenses and $0.5 million is included in research and development expenses on the consolidated statements of income.

⁽²⁾ $0.1 million is included in total cost of sales, $0.7 million is included in selling, general and administrative expenses and $0.7 million is included in research and development expenses on the consolidated statements of income.

⁽³⁾ $0.1 million is included in total cost of sales, $0.7 million is included in selling, general and administrative expenses and $0.6 million is included in research and development expenses on the consolidated statements of income.

⁽⁴⁾ Includes non-cash change in fair value of equity investments held in the ADTRAN, Inc. Deferred Compensation Program for Employees (as amended and restated as of June 1, 2010) per ASU 2016-01, all of which is included in selling, general and administrative expenses on the consolidated statement of income.

⁽⁵⁾ Includes gain related to unearned contingent liabilities recognized upon the acquisition of a business in November 2018.

⁽⁶⁾Includes income related to certain freight forwarder claim settlements which were received during the three months ended June 30, 2019, all of which is included in total cost of sales on the consolidated statements of income.

⁽⁷⁾ $0.4 million is included in total cost of sales, $0.3 million is included in selling, general and administrative expenses and $0.4 million is included in research and development expenses on the consolidated statements of income.

⁽⁸⁾ $0.1 million is included in total cost of sales, $1.0 million is included in selling, general and administrative expenses and $0.7 million is included in research and development expenses on the consolidated statements of income.

⁽⁹⁾ $0.4 million is included in total cost of sales and $0.6 million is included in selling, general and administrative expenses on the consolidated statements of income.

⁽¹⁰⁾ $0.9 million is included in total cost of sales, $1.1 million is included in selling, general and administrative expenses and $1.0 is included in research and development expenses on the consolidated statements of income.

⁽¹¹⁾ $0.2 million is included in total cost of sales, $1.7 million is included in selling, general and administrative expenses and $1.4 million is included in research and development expenses on the consolidated statements of income.

⁽¹²⁾ $0.7 million is included in total cost of sales, $1.5 million is included in selling, general and administrative expenses and $1.2 million is included in research and development expenses on the consolidated statements of income.

⁽¹³⁾ $0.5 million is included in total cost of sales, $0.6 million is included in selling, general and administrative expenses and $0.7 million is included in research and development expenses on the consolidated statements of income.

⁽¹⁴⁾ $0.2 million is included in total cost of sales, $2.0 million is included in selling, general and administrative expenses and $1.4 million is included in research and development expenses on the consolidated statements of income.

⁽¹⁵⁾ $2.8 million is included in total cost of sales, $2.4 million is included in selling, general and administrative expenses and $1.8 million is included in research and development expenses on the consolidated statements of income.

Reconciliation of Net Income (Loss) and Earnings (Loss) per Common Share – Basic and Diluted to Non-GAAP

Net Income (Loss) and Non-GAAP Earnings (Loss) per Common Share – Basic and Diluted


	Three Months ended June 30,						Six Months ended June 30,
	2019			2018			2019			2018
Net Income (Loss)	$	3,995		$	(7,670	)	$	4,765		$	(18,484	)
Acquisition related expenses, amortizations and adjustments		1,506			1,142			3,003			1,725
Stock-based compensation expense		1,454			1,784			3,313			3,603
Restructuring expenses		1,400			1,025			3,463			6,975
Pension expense⁽¹⁾		199			62			402			126
Gain on contingency		(1,230	)		—			(1,230	)		—
Settlement income		(746	)		—			(746	)		—
Gain on bargain purchase of a business		—			—			—			(11,322	)
Tax effect of adjustments to net income (loss)		(714	)		(927	)		(2,238	)		(3,033	)
Non-GAAP Net Income (Loss)	$	5,864		$	(4,584	)	$	10,732		$	(20,410	)

Weighted average shares outstanding – basic		47,802			47,856			47,792			48,043
Weighted average shares outstanding – diluted		48,036			47,856			47,939			48,043

Earnings (loss) per common share - basic	$	0.08		$	(0.16	)	$	0.10		$	(0.38	)
Earnings (loss) per common share - diluted	$	0.08		$	(0.16	)	$	0.10		$	(0.38	)

Non-GAAP earnings (loss) per common share - basic	$	0.12		$	(0.10	)	$	0.22		$	(0.42	)
Non-GAAP earnings (loss) per common share - diluted	$	0.12		$	(0.10	)	$	0.22		$	(0.42	)

⁽¹⁾ Includes amortization of actuarial losses related to the Company's pension plan for employees in certain foreign countries.